Teresa A. TengAssociateK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmail206-370-7838 Professional Biography Teresa A. Teng is an associate at the firm’s Seattle office. She is a member of the corporate/M&A practice group. More Legal and Business Bylines From Teresa A. Teng Chancery Court Finds that Although Alleged Disclosure Deficiency Prevents Application of Corwin, It Is Insufficient to Reasonably Imply Breach of the Duty of Loyalty - (Posted On Tuesday, April 27, 2021) Court Of Chancery Orders Specific Performance Of Merger Agreement, Finding That Fraud Contained In FDA Filings For Approval Of Target Product Did Not Rise To A “Material Adverse Effect” - (Posted On Wednesday, April 01, 2020) Court of Chancery Rules on the Applicability of Forum Selection Clauses to Non-Signatories to a Contract and a Plaintiff’s Burden in Alleging Breach of the “Commercially Reasonable Efforts” Standard - (Posted On Monday, March 30, 2020) Court Of Chancery Applies Political Question Doctrine In Deferring To U.S. President’s Recognition Of Venezuelan President And Holds That Extra-territorial Effects Do Not Preclude Application Of The Act Of State Doctrine - (Posted On Tuesday, October 08, 2019) Current Legal Analysis China’s National Intellectual Property Administration Releases Statistical Data on Patent Licensing from 2019 – 2023 by: Aaron Wininger FTC Approves Final Order Against Seller of AI “Testimonial & Review” Service for Allegedly Providing Subscribers with Means to Generate Deceptive Reviews by: Richard B. Newman Cook County Employers: Time To Update Your Paid Leave Policies by: Alison B. Crane , Sarah J. Gasperini FTC Scrutinizing Healthcare Lead Generators and Marketers as Open Enrollment Begins by: Richard B. Newman Beltway Buzz, December 20, 2024 by: James J. Plunkett Final Regulations Released for Partnership Recourse Liabilities by: Kenneth C. Wang , Jared C. Kassan EPA Finalizes TSCA Risk Management Rules for PCE and TCE by: Mark N. Duvall , Ryan J. Carra The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges by: Adam Herbst Upcoming Events Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
